BOSTON, MA
Allocation by class
Portfolio Concentration
Top 3 weight
67.9%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 17.95M
Full voting authority
17.95M
shares
Joint voting authority
0.00
shares
No voting authority
0.00
shares
Investment Discretion (by position count)
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
Bicara Therapeutics Inc.SOLE | Common Stock | 1.82M | SH | $54.10M 29.14% | 1.82M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | Common Stock Class A | 8.08M | SH | $45.90M 24.72% | 8.08M | 0.00 | 0.00 |
Kestra Med Technologies LtdSOLE | Common Stock | 1.02M | SH | $26.00M 14.00% | 1.02M | 0.00 | 0.00 |
BridgeBio Oncology Therapeutics Inc.SOLE | Common Stock | 3.29M | SH | $25.07M 13.50% | 3.29M | 0.00 | 0.00 |
Beta Bionics Inc.SOLE | Common Stock | 1.32M | SH | $20.62M 11.11% | 1.32M | 0.00 | 0.00 |
Alumis Inc.SOLE | Common Stock | 241.25K | SH | $6.79M 3.66% | 241.25K | 0.00 | 0.00 |
Sana Biotechnology, Inc.SOLE | Common Stock | 843.75K | SH | $2.94M 1.59% | 843.75K | 0.00 | 0.00 |
ImageneBio, Inc.SOLE | Common Stock | 455.36K | SH | $2.69M 1.45% | 455.36K | 0.00 | 0.00 |
enGene Holdings Inc.SOLE | Common Stock | 876.36K | SH | $1.52M 0.82% | 876.36K | 0.00 | 0.00 |
Odyssey Therapeutics Inc.SOLE | Common Stock | 2.89K | SH | $54.1K 0.03% | 2.89K | 0.00 | 0.00 |